Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc V.VER.H

Alternate Symbol(s):  VRSEF

Verisante Technology, Inc. is a Canada-based company. The Company does not operate any active business other than to identify and complete a reverse takeover (RTO) with a company in one of its target sectors that demonstrates significant growth potential and/or value creation opportunities for shareholders. The Company may pursue a target in any industry, it intends to focus its search on companies that meet its acquisition target characteristics within the life sciences sectors.


TSXV:VER.H - Post by User

Verisante Technology Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by life_of_danon Jan 14, 2015 10:07am
78 Views
Post# 23317567

RE:RE:RE:RE:Verisante Technology Announces Brain Tumour Study in the UK

RE:RE:RE:RE:Verisante Technology Announces Brain Tumour Study in the UK
We don't know if this is costing, could be a small amount of revenue.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities